1. Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway
   Cuiju Wang et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
2. Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
   Jianhua Wu et al, 2021, Scientific Reports CrossRef
3. Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression
   Yu-Wen Yeh et al, 2023, Aging CrossRef
4. Dicer induced reactive oxygen species inhibit hepatocellular carcinoma through interacting with cytochrome c oxidase
   Lin Hou et al, 2022, Biotechnology & Biotechnological Equipment CrossRef
5. Dicer Inhibits Hepatocellular Carcinoma by Inhibiting the Interleukin 6 Pathway
   Hongfang Ma et al, 2023, Hepatitis Monthly CrossRef
6. Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells
   Tung-Wei Hsu et al, 2022, Aging CrossRef
7. MicroRNA-Independent Modulation of DICER1 Expression by hAgo2
   Chee-Hing Yang et al, 2020, Molecular and Cellular Biology CrossRef
8. MicroRNA-892a regulates laryngocarcinoma cell proliferation via Dicer
   Jinhui Dong et al, 2020, Experimental Biology and Medicine CrossRef
9. RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma
   Xia Wu et al, 2018, Oncotarget CrossRef
10. Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
    Xin Han et al, 2023, Clinical Medicine Insights: Oncology CrossRef